We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $143.63 · 19 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
Is It Too Late To Reassess Illumina (ILMN) After A 98% One Year Surge? - simplywall.st
Is It Too Late To Reassess Illumina (ILMN) After A 98% One Year Surge? simplywall.st
Illumina Oncology Launches Put Product Depth Against Rapid Share Price Gains - Yahoo Finance Singapore
Illumina Oncology Launches Put Product Depth Against Rapid Share Price Gains Yahoo Finance Singapore
Illumina Ducks DNA Sequence Rival's Antitrust Suit, For Now - Law360
Illumina Ducks DNA Sequence Rival's Antitrust Suit, For Now Law360
Illumina Announces MRD Kit Ahead of ASCO Meeting - Genetic Engineering and Biotechnology News
Illumina Announces MRD Kit Ahead of ASCO Meeting Genetic Engineering and Biotechnology News
Illumina and SPT Labtech launch fireflyGO for automated oncology research - Yahoo Tech
Illumina and SPT Labtech launch fireflyGO for automated oncology research Yahoo Tech
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 07. 30. | After market close (AMC) | $1.22 | — | — | $1.13B | — | Scheduled |
| FY2026 Q1 | 2025. 03. 30. | Time TBD | — | $0.82 | — | — | $1.04B | Reported |
| FY2025 Q3 | 2024. 09. 29. | Time TBD | — | $-8.86 | — | — | $3.27B | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-13.28 | — | — | $2.19B | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 05. | Citigroup | — | Maintain | Sell → Sell | — | Citigroup: Sell |
| 2026. 05. 02. | Canaccord Genuity | — | Maintain | Hold → Hold | — | Canaccord Genuity: Hold |
| 2026. 05. 02. | JP Morgan | — | Maintain | Neutral → Neutral | — | JP Morgan: Neutral |
| 2026. 05. 02. | Barclays | — | Maintain | Underweight → Underweight | — | Barclays: Underweight |
| 2026. 05. 01. | Evercore ISI Group | — | Maintain | Outperform → Outperform | — | Evercore ISI Group: Outperform |
| 2026. 02. 10. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 73,717 | $9.09B | 0.01% | — | New position |
| 2 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 54,317 | $7.12B | 0.01% | — | New position |
| 3 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 53,700 | $6.62B | 0.01% | — | New position |